Evidence map›Paper›PMID 18378775›Full record

ArticleThe Journal of cell biology2008

Myt1 protein kinase is essential for Golgi and ER assembly during mitotic exit.

Hiroyuki Nakajima, Shigenobu Yonemura, Masayuki Murata, Nobuhiro Nakamura, Helen Piwnica-Worms, Eisuke Nishida

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Mechanisms and Regulation of the Mitotic Inheritance of the Golgi Complex.Frontiers in cell and developmental biology · 2015
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Hiroyuki NakajimaDepartment of Cell and Developmental Biology, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto 606-8502, Japan.
Shigenobu Yonemura
Masayuki Murata
Nobuhiro Nakamura
Helen Piwnica-Worms
Eisuke Nishida
Kyoto University · JPHoward Hughes Medical Institute · USKanazawa University · JPThe University of Tokyo · JP

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Myt1 was originally identified as an inhibitory kinase for Cdc2 (Cdk1), the master engine of mitosis, and has been thought to function, together with Wee1, as a negative regulator of mitotic entry. In this study, we report an unexpected finding that Myt1 is essential for Golgi and endoplasmic reticulum (ER) assembly during telophase in mammalian cells. Our analyses reveal that both cyclin B1 and cyclin B2 serve as targets of Myt1 for proper Golgi and ER assembly to occur. Thus, our results show that Myt1-mediated suppression of Cdc2 activity is not indispensable for the regulation of a broad range of mitotic events but is specifically required for the control of intracellular membrane dynamics during mitosis.

Indexed as

AnimalsCell Cycle ProteinsCyclin BCyclin B1DNA-Binding ProteinsEndoplasmic ReticulumGolgi ApparatusHeLa CellsHumansNuclear ProteinsProtein-Tyrosine KinasesRNA, Small InterferingTelophaseTranscription FactorsCCNB1 protein, humanCell Cycle ProteinsCyclin BCyclin B1DNA-Binding ProteinsMYT1 protein, humanNuclear ProteinsProtein-Tyrosine KinasesRNA, Small InterferingTranscription FactorsWEE1 protein, human

Identifiers

PMID18378775
PMCPMC2287290
OpenAlexW2134435988

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.